Altimmune (ALT) News
NASDAQ: ALTHealthcareBiotechnologyUSD
2.61+0.01 (+0.38%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ALT news summary
We found 1 recent headline mentioning Altimmune (ALT): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, ALT is up 0.38% at $2.61. The most recent story, "Can NVO's Semaglutide Push Create Growth Beyond Cardiometabolic Care?", was published by Nasdaq on Oct 7, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology